
FAK
Os inibidores da quinase de adesão focal (FAK) têm como alvo a FAK, uma quinase envolvida na adesão celular, migração e angiogênese. A FAK é frequentemente superexpressa em tumores e contribui para a formação de novos vasos sanguíneos que fornecem nutrientes ao tumor. Inibir a FAK pode interromper esses processos, tornando os inibidores de FAK ferramentas valiosas na terapia do câncer e na pesquisa de angiogênese. Na CymitQuimica, oferecemos uma gama abrangente de inibidores de FAK de alta qualidade para apoiar sua pesquisa em biologia celular, câncer e angiogênese.
Foram encontrados 74 produtos para "FAK".
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
Roslin 2 bromide
CAS:Roslin 2 bromide (Benzylhexamethylenetetramine bromide) is a p53 reactivator that disrupts the binding of FAK and p5.Fórmula:C13H19BrN4Pureza:99.34%Cor e Forma:SolidPeso molecular:311.221FC 11
CAS:FC 11 is a reversible FAK PROTAC Degrader with DC50 of 40-370 pM and degrades pFAKtyr397 in TM3 cells within 3 hours at 100 nM.Fórmula:C41H42F3N13O9SCor e Forma:SolidPeso molecular:949.91Ifebemtinib
CAS:Ifebemtinib (BI-853520) is an adhesion plaque kinase inhibitor with anti-tumour activity for the study of breast cancer.Fórmula:C28H28F4N6O4Pureza:98.47% - 99.93%Cor e Forma:White SolidPeso molecular:588.5533FAK-IN-3
FAK-IN-3 inhibits FAK, reduces PA-1 cell migration/invasion, and tumor growth, with no major side effects.Fórmula:C28H28N6O4Cor e Forma:SolidPeso molecular:512.56FAK-IN-23
CAS:FAK-IN-23 (Compound II) is an inhibitor of focal adhesion kinase (FAK).Fórmula:C32H38F3N5O8Cor e Forma:SolidPeso molecular:677.668FAK-IN-26
CAS:FAK-IN-26 is a blood-brain barrier-penetrating inhibitor of Focal Adhesion Kinase (FAK) with an IC50 of 0.87 nM. It significantly reduces tumor cell viability, cancer stem cell activity, and cell migration in A549 and SKOV-3 cell lines. FAK-IN-26 exhibits potent anticancer activity, achieving tumor inhibition rates of 59.15% and 57.9% in A549 and SKOV-3 tumor mouse models, respectively.Fórmula:C20H19BrFN5O2Cor e Forma:SolidPeso molecular:460.30OXA-11
CAS:OXA-11 (FAK-IN-16) is a FAK inhibitor with anti-tumor activity, useful for cancer research.Fórmula:C37H49F3N7O5PPureza:98.70% - 99.20%Cor e Forma:White SolidPeso molecular:759.8FAK-IN-21
CAS:FAK-IN-21 (compound 9) is a FAK inhibitor with an IC50 value of 37.52 nM. It inhibits cell growth and the phosphorylation of FAK, making it useful for research into diffuse gastric cancer.Fórmula:C22H22F2N8O3SCor e Forma:SolidPeso molecular:516.52FAK inhibitor 6
CAS:Compound 26F: potent enzyme inhibitor (IC50=28.2nM), low cytotoxicity (IC50=3.32μM), induces dose-dependent apoptosis in MDA-MB-231, blocks G0/G1 phase.Fórmula:C25H24FN5O2SCor e Forma:SolidPeso molecular:477.55FAK activator-1
CAS:FAKactivator-1 (5aHCl) is a compound that functions as a FAK activator and mucosal healing inducer. It enhances the phosphorylation of FAK at the Tyr-397 site, thereby facilitating FAK activation. This agent promotes mucosal healing and is applicable in research related to gastrointestinal mucosal injury associated with non-steroidal anti-inflammatory drugs.Fórmula:C21H27ClF3N5O2Peso molecular:473.92JP-153
CAS:JP-153 is an inhibitor of Src-FAK-Paxillin signaling. It suppresses Src-dependent phosphorylation of paxillin (Y118) and subsequent activation of Akt (S473). JP-153 reduces VEGF-induced migration and proliferation of retinal endothelial cells and is applicable in the study of neovascular eye diseases.Fórmula:C21H19NO5Cor e Forma:SolidPeso molecular:365.379Pyk2-IN-2
CAS:Pyk2-IN-2 (compound 13j) acts as a Pyk2 inhibitor, exhibiting an IC 50 value of 0.608 μM for FAK kinase [1].Fórmula:C27H27N7OCor e Forma:SolidPeso molecular:465.55FAK-IN-6
FAK-IN-6: Potent FAK inhibitor (IC50=1.415 nM), anti-cancer, for pancreatic studies.Fórmula:C25H31ClN5O6PSCor e Forma:SolidPeso molecular:596.04Ifebemtinib tosylate
CAS:Ifebemtinib (tosylate) (BI-853520 (tosylate); IN-10018 (tosylate)) is a highly selective PTK2 kinase inhibitor with anti-tumor properties. It inhibits FAK autophosphorylation in prostate cancer cells and suppresses spheroid formation and in situ tumor growth in vivo. Ifebemtinib (tosylate) is applicable in cancer research, including studies on solid tumors, breast cancer, and malignant pleural mesothelioma.Fórmula:C35H36F4N6O7SCor e Forma:SolidPeso molecular:760.76

